Previous 10 |
home / stock / ngmdf / ngmdf news
TORONTO, ON / ACCESSWIRE / September 28, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the " Company ") announces that, further to its press release on September 15, 2022, the TSX Venture Exchange (" TSXV ") has approved the Company's application to extend the expiry date and reduce the exe...
TORONTO, ON / ACCESSWIRE / September 16, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce the appointment of Greg Gironda to the Company's Advisory Board. Greg Gironda has over 30 years of...
TORONTO, ON / ACCESSWIRE / September 12, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that, effective September 9, 2022, its common shares have received Depository Trust Company ("DTC")...
TORONTO, ON / ACCESSWIRE / July 27, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that, effective July 27, 2022, its common shares will commence trading on the OTCQB under the symbol NGM...
News, Short Squeeze, Breakout and More Instantly...
NuGen Medical Devices Company Name:
NGMDF Stock Symbol:
OTCMKTS Market:
NuGen Medical Devices Website:
Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce its intention to complete a non-brokered private placement (the ...
Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that it has formed a three-way partnership with Wholehealth Pharm...
Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of June 26, 2024, the commercial teams of Sol-Millennium ...